Self-myofascial Release in Hemophilic Ankle Arthropathy
Hemophilia
About this trial
This is an interventional treatment trial for Hemophilia focused on measuring Hemophilic arthropathy, Ankle, Self-myofascial release, Safety, Joint pain, Functionality
Eligibility Criteria
Inclusion Criteria:
- Being over 18 years old
- Patients with a medical diagnosis of hemophilia A or B.
- Patients with a severe phenotype of hemophilia (<1% FVIII/FIX).
- Patients with a medical diagnosis of hemophilic ankle arthropathy and more than 3 points on the Hemophilia Joint Health Score.
- Nno scheduled orthopedic surgeries during the study phase.
- Signing the informed consent document.
Exclusion Criteria:
- Patients with ankle hemarthrosis in the month before the beginning of the study.
- Patients unable to walk even with technical aids.
Patients with hemophilic elbow arthropathy that prevented the performance of the exercises.
- Patients failing to complete at least 80% of the sessions scheduled in the intervention
Sites / Locations
- University of Murcia
Arms of the Study
Arm 1
Experimental
Self-myofascial release
Each session will last approximately 15 minutes, with five physiotherapy sessions taking place over a period of 3 months. The Self-Myofascial release protocol for the lower limbs using a Foam Roller and and Solid Ball Massage, adapted to patients with hemophilic ankle arthropathy will include 11 exercises that must be administered bilaterally. A mobile application will be developed where each patient will be able to observe the exercises to be carried out.